Goldman Sachs’s Baird Medical Investment Holdings Warrant BDMDW Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$17.6K Hold
220,004
﹤0.01% 6363
2025
Q4
$11.2K Hold
220,004
﹤0.01% 6364
2025
Q3
$14.3K Hold
220,004
﹤0.01% 6243
2025
Q2
$17.6K Hold
220,004
﹤0.01% 5989
2025
Q1
$16.5K Hold
220,004
﹤0.01% 5952
2024
Q4
$45.1K Buy
+220,004
New +$8.71K ﹤0.01% 5848

Other funds holding BDMDW

Goldman Sachs's BDMDW Position: Q1 2026 in Review

Goldman Sachs held its Baird Medical Investment Holdings Warrant (BDMDW) position steady in Q1 2026 at 220,004 shares worth $17.6K. The position accounts for ﹤0.01% of the portfolio, ranked #6363.

Goldman Sachs first reported a position in BDMDW in Q4 2024 and has held it in 6 quarters since. The position peaked at $45.1K in Q4 2024. 27 funds tracked by Wall St. Rank hold BDMDW as of Q1 2026.

  • Goldman Sachs held 220,004 shares of Baird Medical Investment Holdings Warrant worth $17.6K as of Q1 2026.
  • Goldman Sachs left its Baird Medical Investment Holdings Warrant share count unchanged in Q1 2026.
  • Baird Medical Investment Holdings Warrant made up ﹤0.01% of Goldman Sachs's portfolio in Q1 2026, its #6363 holding.
  • Goldman Sachs first reported a position in Baird Medical Investment Holdings Warrant in Q4 2024 and has held it in 6 quarters since.
  • Goldman Sachs's Baird Medical Investment Holdings Warrant position peaked at $45.1K in Q4 2024.
  • 27 funds tracked by Wall St. Rank held Baird Medical Investment Holdings Warrant as of Q1 2026.

Based on Goldman Sachs's 13F filing for Q1 2026, filed 15 May 2026.